- English (UK)
- English (India)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Oramed Pharmaceuticals Inc (ORMP)
Oramed Pharmaceuticals Inc stock price live, this page displays NASDAQ ORMP stock exchange data. View the ORMP premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the Oramed Pharmaceuticals Inc real time stock price chart below.
What Is the Oramed Pharmaceuticals Inc Stock Price Today?
The Oramed Pharmaceuticals Inc stock price today is 3.820.
What Is the Stock Symbol for Oramed Pharmaceuticals Inc?
The stock ticker symbol for Oramed Pharmaceuticals Inc is ORMP.
Is ORMP the Same as $ORMP?
$ORMP is a common way to refer to the Oramed Pharmaceuticals Inc ticker symbol in social media, forums, and online discussions. The dollar sign is a shorthand convention used to indicate that it is a stock ticker symbol
What Stock Exchange Does Oramed Pharmaceuticals Inc Trade On?
Oramed Pharmaceuticals Inc is listed and trades on the NASDAQ stock exchange.
Is Oramed Pharmaceuticals Inc a Good Stock to Buy?
Determining whether Oramed Pharmaceuticals Inc—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess the current Oramed Pharmaceuticals Inc share price compared with the fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the ORMP quote. (ISIN: US68403P2039)
What Is the Oramed Pharmaceuticals Inc Stock Price Today?
The Oramed Pharmaceuticals Inc stock price today is 3.820.
What Is the Stock Symbol for Oramed Pharmaceuticals Inc?
The stock ticker symbol for Oramed Pharmaceuticals Inc is ORMP.
Is ORMP the Same as $ORMP?
$ORMP is a common way to refer to the Oramed Pharmaceuticals Inc ticker symbol in social media, forums, and online discussions. The dollar sign is a shorthand convention used to indicate that it is a stock ticker symbol
What Stock Exchange Does Oramed Pharmaceuticals Inc Trade On?
Oramed Pharmaceuticals Inc is listed and trades on the NASDAQ stock exchange.
Is Oramed Pharmaceuticals Inc a Good Stock to Buy?
Determining whether Oramed Pharmaceuticals Inc—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess the current Oramed Pharmaceuticals Inc share price compared with the fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the ORMP quote. (ISIN: US68403P2039)
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
3.730
3.905
52 wk Range
1.975
3.910
High dividend Yield
1/2
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
3.7303.905
52 wk Range
1.9753.910
Key Statistics
Edit
Prev. Close
Open
Volume
Average Vol. (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
(6.54%)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Prev. Close
Open
Volume
Average Vol. (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
(6.54%)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
ORMP Scorecard
Company’s Health
Assesses a company's financial position by analyzing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Buy
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Holds more cash than debt on its balance sheet
- Form 8K Oramed Pharmaceuticals Inc For: 20 February
- Investing.com
- Lifeward closes strategic partnership with Oramed
- Investing.com
- Form 8K Oramed Pharmaceuticals Inc For: 14 January
- Investing.com
- Lifeward closes strategic partnership with Oramed
- Investing.com
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Buy
Technical Indicators
Strong Buy
Moving Averages
Strong Buy
Oramed Pharmaceuticals Inc. engages in the research and development of pharmaceutical solutions with a technology platform for the oral delivery of therapeutic proteins. It develops ORMD-0801, an oral insulin capsule, which is in phase III clinical trial for the treatment of individuals with diabetes. The company has license agreements with Oravax Medical Inc. to commercialize oral vaccines for COVID-19 and other novel coronaviruses. Oramed Pharmaceuticals Inc. was incorporated in 2002 and is headquartered in New York, New York.
Compare ORMP to Peers and Sector
Metrics to compare | ORMP | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipORMPPeersSector | |
|---|---|---|---|---|
P/E Ratio | 2.4x | −4.5x | −0.5x | |
PEG Ratio | 0.01 | −0.01 | 0.00 | |
Price / Book | 0.8x | 2.9x | 2.6x | |
Price / LTM Sales | 77.3x | 3.7x | 3.2x | |
Upside (Analyst Target) | 64.5% | 79.7% | 47.6% | |
Fair Value Upside | Unlock | 6.1% | 6.1% | Unlock |
Earnings
Latest Release
Feb 25, 2026
EPS / Forecast
-- / -0.08
Revenue / Forecast
-- / --
People Also Watch
FAQ
What Is the Oramed (ORMP) Stock Price Today?
The Oramed stock price today is 3.820 USD.
What Stock Exchange Does Oramed Trade On?
Oramed is listed and trades on the Nasdaq Stock Exchange.
What Is the Stock Symbol for Oramed?
The stock symbol for Oramed is "ORMP."
Does Oramed Pay Dividends? What’s The Current Dividend Yield?
The Oramed dividend yield is 6.54%.
What Is the Oramed Market Cap?
As of today, Oramed market cap is 154.300M USD.
What Is Oramed's Earnings Per Share (TTM)?
The Oramed EPS (TTM) is 1.499.
When Is the Next Oramed Earnings Date?
Oramed will release its next earnings report on Jun 03, 2026.
From a Technical Analysis Perspective, Is ORMP a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.
How Many Times Has Oramed Stock Split?
Oramed has split 2 times.
How Many Employees Does Oramed Have?
Oramed has 4 employees.
What is the current trading status of Oramed (ORMP)?
As of Apr 15, 2026, Oramed (ORMP) is trading at a price of 3.820 USD, with a previous close of 3.800 USD. The stock has fluctuated within a day range of 3.730 USD to 3.905 USD, while its 52-week range spans from 1.975 USD to 3.910 USD.
What Is Oramed (ORMP) Price Target According to Analysts?
The average 12-month price target for Oramed is 6.250 USD, with a high estimate of 6.25 USD and a low estimate of 6.25 USD. 0 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Strong Buy. The stock has an +63.61% Upside potential.
What Is the ORMP Premarket Price?
ORMP's last pre-market stock price is 3.840 USD. The pre-market share volume is 2,550.000, and the stock has decreased by 0.040, or 1.050%.
What Is the ORMP After Hours Price?
ORMP's last after hours stock price is 3.810 USD, the stock has decreased by -0.010, or -0.260%.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.